FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lamisil Tablets
Status: Discontinuation
»Therapeutic Categories:

Novartis (New 11/15/2017)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
Lamisil Tablets 250mg Bottles of 30 (NDC 0078-0179-15) 11/15/2017 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Lamisil Tablets 250mg. Discontinuation of the product is not due to manufacturing, product quality, safety, or efficacy concerns. Lamisil Tablets 250mg will be available until approximately the end of April 2018.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English